Position in TAK
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$268,244
-$20,519 QoQ
Shares Held
16,734
+7.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#188
of 375 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Ascent Group, LLC holds $3,280,030 across 8 Drug Manufacturers - Specialty & Generic names. TAK ranks #5 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
10,866 | $780,830 | |
| 2 | HLN |
Haleon plc
|
76,122 | $710,216 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,220 | $661,032 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
4,101 | $454,964 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
16,734 | $268,244 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
3,273 | $209,307 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
|
10,828 | $156,897 | |
| 8 | ALVO |
Alvotech
|
10,445 | $38,540 |
All Filings in TAK
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $268,244 | 16,734 | Shares | Other | 2026-08-03 | |
| 2026-03-31 | $288,763 | 15,592 | Shares | Other | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||